You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (21)

Journals (0)

1-10 of 21 results for Acalabrutinib

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: CNS Aspergillosis and Cryptococcosis with Cytomegalovirus Pneumonia in a Patient with Chronic Lymphocytic Leukemia Treated with Acalabrutinib

Retricted access

Case report

First published 2024-12

CNS Aspergillosis and Cryptococcosis with Cytomegalovirus Pneumonia in a Patient with Chronic Lymphocytic Leukemia Treated with Acalabrutinib

Taylor Fallin, Erica Thacker, Syeda Sahra [...]

Journal of Pharmacy Practice

Select article: The role of acalabrutinib in adults with chronic lymphocytic leukemia

Open access

Review article

First published 2021

The role of acalabrutinib in adults with chronic lymphocytic leukemia

Bita Fakhri, Charalambos Andreadis

Therapeutic Advances in Hematology

Select article: Cost-effectiveness of acalabrutinib monotherapy or with obinutuzumab versus chemoimmunotherapy for untreated chronic lymphocytic leukemia in China

Open access

Research article

First published 2024

Cost-effectiveness of acalabrutinib monotherapy or with obinutuzumab versus chemoimmunotherapy for untreated chronic lymphocytic leukemia in China

Mengya Li, Xiaoyan Zhong, Chengbin Zhang [...]

Therapeutic Advances in Hematology

Select article: Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia

Open access

Research article

First published 2023

Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia

Wojciech Jurczak, Nagah Elmusharaf, Christopher P. Fox [...]

Therapeutic Advances in Hematology

Select article: Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature

Open access

Case report

First published 2024

Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature

Alberto Fresa, Idanna Innocenti, Annamaria Tomasso [...]

Therapeutic Advances in Hematology

Select article: Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)

Open access

Brief report

First published 2025

Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)

Mazyar Shadman, Jennifer R. Brown, Rhys Williams [...]

Therapeutic Advances in Medical Oncology

Select article: Evaluation of second-generation Bruton's tyrosine kinase inhibitors for the treatment of mantle cell lymphoma

Open access

Research article

First published 2025-4

Evaluation of second-generation Bruton's tyrosine kinase inhibitors for the treatment of mantle cell lymphoma

Jessie Lu, Bryan Do, Brian Primeaux

Journal of Oncology Pharmacy Practice

Select article: BTK inhibitors and anti-CD20 monoclonal antibodies for treatment-naïve elderly patients with CLL

Open access

Review article

First published 2020

BTK inhibitors and anti-CD20 monoclonal antibodies for treatment-naïve elderly patients with CLL

Andrew Rogers, Jennifer A. Woyach

Therapeutic Advances in Hematology

Select article: Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia: A review

Retricted access

Review article

First published 2021-12

Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia: A review

Donald C Moore

Journal of Oncology Pharmacy Practice

Select article: The evolving role of Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia

Open access

Review article

First published 2021

The evolving role of Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia

Max J. Gordon, Alexey V. Danilov

Therapeutic Advances in Hematology

1
2
3
10 / page

Article type

Publication date

Subjects

Access